TRIAP1 and nasopharyngeal carcinoma: Simultaneously, miR-320b was confirmed and validated as a negative regulator of TP53-regulated inhibitor of apoptosis (TRIAP1), and its association with the development of nasopharyngeal carcinoma has been proved [32].